• intent@hq.icmr.org.in

Existing gaps

  • India with 18% of the global population conducts only 1·4% of global clinical trials.
  • Regulatory clinical trial capacity traditionally exist with pharmaceutical industry and CROs.
  • Individuals are frequently sceptic to participate.
  • Academic centres lack critical capacity in areas such as regulatory compliance, data management, etc. and restrict themselves to Non-regulatory trials.

Phase-II/III Trial Centers

Zoomable Image

# Institute Details
57 JIPMER Puducherry
58 St. John’s Medical College, Bengaluru
59 Amrita Institute of Medical Sciences, Kochi
60 LV Prasad Eye Institute, Hyderabad
61 Sri Ramachandra Institute of Higher Education, Chennai
62 Christian Medical College, Vellore, Tamil Nadu
63 Yenepoya Medical College Hospital, Yenepoya (Deemed to be University) City, Mangalore, Karnataka
64 ICMR-National Institute of Traditional Medicine, Belagavi, Karnataka
65 JSS Academy of Higher Education and Research, Mysuru, Karnataka
66 Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka
67 Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education,Chengalpattu, Chennai, Tamilnadu
68 Gandhi Medical College, Secunderabad, Telangana
69 Tirunelveli Medical College, Tirunelveli, Tamil Nadu
70 Karnataka Institute of Medical Sciences, Hubli, Karnataka Delhi
71 Pondicherry Institute of Medical Sciences, Puducherry
72 DM Wayanad Medical College, Waynad, Kerala
73 Narayana Medical College & Hospital, Nellore
74 Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research Belagavi, Karnataka
75 SRM Medical College Hospital & Research Centre, Chennai, Tamil Nadu
76 National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu
77 National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka
78 Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum
79 The George Institute of Public Health, Hyderabad, Telangana
80 Indira Gandhi Institute of Child Health, Bangalore, Karnataka
81 SAT Hospital, Government Medical College, Thiruvananthapuram, Kerala
82 Nizam's Institute of Medical Sciences, Hyderabad, Telangana
83 Institute of Child Health And Hospital for Children, Egmore, Chennai, Tamilnadu
84 ICMR - National Institute of Nutrition, Hyderabad

Expected outcomes

  • Build capacity of investigators through training and collaboration.
  • Improve capability to conduct academic as well as regulatory clinical trials.
  • Improve the clinical trial ecosystem by trial methodology research, frequent interaction with stakeholders, regulatory research etc.
  • Improve representation of the diverse Indian community.
  • Instil confidence in Indian study participants through transparency and advocacy.
  • Identify and support a plug-and-play clinical trial network that can readily evaluate health products that are of national health priority.
  • Conduct large decisive trials, in areas of National Health Priorities.
  • Clinical development of indigenous drugs, vaccines, devices and diagnostics.
  • Provide evidence-based, cost effective, scientifically sound and culturally sensitive solutions to problems.
  • Influence health policies and practices.